{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:57:43Z","timestamp":1768831063640,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00345-019-02830-7","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T12:38:00Z","timestamp":1559392680000},"page":"957-964","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7890-040X","authenticated-orcid":false,"given":"Antonio B.","family":"Porcaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Sebben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Novella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Processali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pirozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelia","family":"Amigoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Rizzetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliasger","family":"Shakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Mariotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Angela","family":"Cerruto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Enrico","family":"Cacciamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Siracusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Artibani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"issue":"7","key":"2830_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1002\/ijc.29538","volume":"137","author":"KJ Bell","year":"2015","unstructured":"Bell KJ et al (2015) Prevalence of incidental prostate cancer: a systematic review of autopsy studies. Int J Cancer 137(7):1749\u20131757","journal-title":"Int J Cancer"},{"issue":"3","key":"2830_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ucl.2016.04.001","volume":"43","author":"KB Egan","year":"2016","unstructured":"Egan KB (2016) The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin N Am 43(3):289\u2013297","journal-title":"Urol Clin N Am"},{"issue":"1","key":"2830_CR3","doi-asserted-by":"publisher","first-page":"9763","DOI":"10.1038\/s41598-017-10068-9","volume":"7","author":"A Bhowal","year":"2017","unstructured":"Bhowal A et al (2017) Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression. Sci Rep 7(1):9763","journal-title":"Sci Rep"},{"issue":"6","key":"2830_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"C Gratzke","year":"2015","unstructured":"Gratzke C et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099\u20131109","journal-title":"Eur Urol"},{"issue":"4","key":"2830_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618\u2013629","journal-title":"Eur Urol"},{"issue":"3","key":"2830_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jama.282.3.236","volume":"282","author":"JN Krieger","year":"1999","unstructured":"Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282(3):236\u2013237","journal-title":"JAMA"},{"issue":"2","key":"2830_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MOU.0000000000000369","volume":"27","author":"G Gandaglia","year":"2017","unstructured":"Gandaglia G et al (2017) The role of prostatic inflammation in the development and progression of benign and malignant diseases. Curr Opin Urol 27(2):99\u2013106","journal-title":"Curr Opin Urol"},{"issue":"1","key":"2830_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","volume":"15","author":"KS Sfanos","year":"2018","unstructured":"Sfanos KS et al (2018) The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol 15(1):11","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2830_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","volume":"15","author":"KS Sfanos","year":"2018","unstructured":"Sfanos KS et al (2018) The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol 15(1):11\u201324","journal-title":"Nat Rev Urol"},{"issue":"4","key":"2830_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000488882","volume":"100","author":"AB Porcaro","year":"2018","unstructured":"Porcaro AB et al (2018) Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: retrospective study of 738 consecutive cases elected to a first random biopsy set. Urol Int 100(4):456\u2013462","journal-title":"Urol Int"},{"issue":"5","key":"2830_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5301\/tj.5000573","volume":"103","author":"AB Porcaro","year":"2017","unstructured":"Porcaro AB et al (2017) Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set. Tumori 103(5):475\u2013482","journal-title":"Tumori"},{"issue":"5","key":"2830_CR12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.juro.2017.11.120","volume":"199","author":"SR Vasavada","year":"2018","unstructured":"Vasavada SR et al (2018) Inflammation on prostate needle biopsy is associated with lower prostate cancer risk: a meta-analysis. J Urol 199(5):1174\u20131181","journal-title":"J Urol"},{"issue":"1","key":"2830_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/pros.23442","volume":"78","author":"S Davidsson","year":"2018","unstructured":"Davidsson S et al (2018) FOXP3(+) regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer. Prostate 78(1):40\u201347","journal-title":"Prostate"},{"issue":"10","key":"2830_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrurol.2016.168","volume":"13","author":"C De Nunzio","year":"2016","unstructured":"De Nunzio C, Presicce F, Tubaro A (2016) Inflammatory mediators in the development and progression of benign prostatic hyperplasia. Nat Rev Urol 13(10):613\u2013626","journal-title":"Nat Rev Urol"},{"issue":"4","key":"2830_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.5301\/tj.5000607","volume":"103","author":"AB Porcaro","year":"2017","unstructured":"Porcaro AB et al (2017) Prostate volume index stratified prostate cancer risk in patients elected to a first random biopsy set. Tumori 103(4):374\u2013379","journal-title":"Tumori"},{"issue":"3","key":"2830_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000362176","volume":"94","author":"AB Porcaro","year":"2015","unstructured":"Porcaro AB et al (2015) Prostate volume index and chronic inflammation of the prostate type IV with respect to the risk of prostate cancer. Urol Int 94(3):270\u2013285","journal-title":"Urol Int"},{"issue":"1","key":"2830_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000447432","volume":"98","author":"AB Porcaro","year":"2017","unstructured":"Porcaro AB et al (2017) Prostate volume index associates with a decreased risk of prostate cancer: results of a large cohort of patients elected to a first biopsy set. Urol Int 98(1):22\u201327","journal-title":"Urol Int"},{"issue":"2","key":"2830_CR18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI et al (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40(2):244\u2013252","journal-title":"Am J Surg Pathol"},{"issue":"30","key":"2830_CR19","doi-asserted-by":"publisher","first-page":"7546","DOI":"10.1200\/JCO.2005.05.525","volume":"23","author":"SJ Freedland","year":"2005","unstructured":"Freedland SJ et al (2005) Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol 23(30):7546\u20137554","journal-title":"J Clin Oncol"},{"issue":"1","key":"2830_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.juro.2012.12.108","volume":"190","author":"DP Ankerst","year":"2013","unstructured":"Ankerst DP et al (2013) The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator. J Urol 190(1):70\u201376","journal-title":"J Urol"},{"issue":"2","key":"2830_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00345-011-0804-y","volume":"30","author":"MJ Roobol","year":"2012","unstructured":"Roobol MJ et al (2012) Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. World J Urol 30(2):149\u2013155","journal-title":"World J Urol"},{"issue":"2","key":"2830_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000277591","volume":"84","author":"CX Raventos","year":"2010","unstructured":"Raventos CX et al (2010) Preoperative prediction of pathologically insignificant prostate cancer in radical prostatectomy specimens: the role of prostate volume and the number of positive cores. Urol Int 84(2):153\u2013158","journal-title":"Urol Int"},{"issue":"1","key":"2830_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","volume":"60","author":"C De Nunzio","year":"2011","unstructured":"De Nunzio C et al (2011) The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 60(1):106\u2013117","journal-title":"Eur Urol"},{"issue":"2","key":"2830_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4103\/1008-682X.140966","volume":"17","author":"TR Jarvis","year":"2015","unstructured":"Jarvis TR, Chughtai B, Kaplan SA (2015) Testosterone and benign prostatic hyperplasia. Asian J Androl 17(2):212\u2013216","journal-title":"Asian J Androl"},{"issue":"4","key":"2830_CR25","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00261-016-0975-5","volume":"42","author":"DT Oberlin","year":"2017","unstructured":"Oberlin DT et al (2017) Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer. Abdom Radiol (NY) 42(4):1255\u20131258","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"2830_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0301-5629(98)00039-8","volume":"24","author":"S Tong","year":"1998","unstructured":"Tong S et al (1998) Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging. Ultrasound Med Biol 24(5):673\u2013681","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"2830_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0022-5347(18)35422-3","volume":"173","author":"CG Roehrborn","year":"2005","unstructured":"Roehrborn CG et al (2005) 1277: the impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study. J Urol 173(4):346","journal-title":"J Urol"},{"issue":"2","key":"2830_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000447199","volume":"11","author":"AB Porcaro","year":"2018","unstructured":"Porcaro AB et al (2018) Associations of transitional zone volume with intraprostatic chronic inflammation and prostate cancer risk in patients undergoing a first random biopsy set. Curr Urol 11(2):85\u201391","journal-title":"Curr Urol"},{"issue":"3","key":"2830_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000447164","volume":"10","author":"AB Porcaro","year":"2016","unstructured":"Porcaro AB et al (2016) Low-risk prostate cancer and tumor upgrading in the surgical specimen: analysis of clinical factors predicting tumor upgrading in a contemporary series of patients who were evaluated according to the modified gleason score grading system. Curr Urol 10(3):118\u2013125","journal-title":"Curr Urol"},{"issue":"3","key":"2830_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5301\/tj.5000546","volume":"103","author":"AB Porcaro","year":"2017","unstructured":"Porcaro AB et al (2017) Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer. Tumori J 103(3):299\u2013306","journal-title":"Tumori J"},{"issue":"4","key":"2830_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1159\/000476039","volume":"99","author":"AB Porcaro","year":"2017","unstructured":"Porcaro AB et al (2017) Clinical factors predicting bilateral lymph node invasion in high-risk prostate cancer. Urol Int 99(4):392\u2013399","journal-title":"Urol Int"},{"issue":"2","key":"2830_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000458763","volume":"99","author":"AB Porcaro","year":"2017","unstructured":"Porcaro AB et al (2017) Clinical factors predicting and stratifying the risk of lymph node invasion in localized prostate cancer. Urol Int 99(2):207\u2013214","journal-title":"Urol Int"},{"issue":"1","key":"2830_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000452631","volume":"98","author":"AB Porcaro","year":"2017","unstructured":"Porcaro AB et al (2017) Clinical factors of disease reclassification or progression in a contemporary cohort of prostate cancer patients elected to active surveillance. Urol Int 98(1):32\u201339","journal-title":"Urol Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02830-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-02830-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02830-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T02:20:02Z","timestamp":1663554002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-02830-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2830"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-02830-7","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]},"assertion":[{"value":"31 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}